Categories
Articles

Kinnov-Therapeutics Completes Recruitment of KT-110 Phase 2 Clinical Trial in Alcohol Dependence Disorders – Business Wire

Kinnov-Therapeutics Completes Recruitment of KT-110 Phase 2 Clinical Trial in Alcohol Dependence Disorders  Business Wire
source

Leave a Reply

Your email address will not be published. Required fields are marked *